The AAA, CSAA, Microsoft and Motorola Solutions-backed emergency response software developer’s latest round, led by Insight Partners, brought its total funding to $200m.

Existing strategic investor Allogene Therapeutics has taken part in an $85m series A round for Notch Therapeutics, which is working on cancer treatments.

The WuXi AppTec-backed round will help the hepatitis B drug developer begin human trials for its lead drug candidate.

The Bimbo and Femsa-backed online grocer has now received over $100m in total, having raised $65m from venture capital investors for its series A round.

China Merchants Group participated in a series C-plus round for the cancer and inflammatory disease drug developer.

The probiotics developer secured an undisclosed amount as Cargill co-led the first close of a series D round with a $55m target.

The Telus Ventures-backed debt recovery software provider has secured over $100m in total, Inovia Capital having led its series B-plus round.

Oko Markets was among the backers in a $1.9m close of the logistics technology developer’s series B round, which already included Emtek, EV Growth and SoftBank Ventures Asia.

Sumitomo Heavy Industries invested $46m in the energy storage system developer through a round that included Janus Continental Group and TSK.

Today's deal net contains news from Boston Metal, Evologic Therapeutics, Lilz, GaitQ, Hemerion Therapeutics and Rebrain.